Dublin, Sept. 01, 2021 (GLOBE NEWSWIRE) -- The "Oligonucleotides: Global Markets to 2026" report has been added to ResearchAndMarkets.com's offering.
The global market for oligonucleotide synthesis should grow from $6.1 billion in 2021 to $10.2 billion by 2026 with a compound annual growth rate (CAGR) of 10.7% for the period of 2021-2026.
The oligonucleotide drugs market should grow from $4.3 billion in 2021 to $7.2 billion by 2026 with a compound annual growth rate (CAGR) of 11.0% for the period of 2021-2026.
The synthesized oligos market should grow from $1.1 billion in 2021 to $1.7 billion by 2026 with a compound annual growth rate (CAGR) of 9.6% for the period of 2021-2026.
This report covers the worldwide market for oligonucleotide synthesis, which consists of four main product types: oligonucleotide drugs, synthesized oligos, equipment and reagents, and services. Based on application, the market for oligonucleotide synthesis is divided into research and diagnostics and therapeutics.
Along with its diagnostics and research uses, oligonucleotides are also being used as therapeutic drugs for a wide range of diseases. This type of drug focuses on the gene-silencing technique, as well as splice modulation and gene activation modalities for treatment. Oligonucleotide drugs offer personalized medicine approaches to target the specific gene sequences responsible for the occurrence of a specific disease.
The first approved oligonucleotide drug was Vitravene (fomivirsen) in 1998 for the treatment of cytomegalovirus retinitis (CMV). To date, more than 14 drugs have received FDA approval for therapeutic usage for the treatment of liver, spinal cord and skeletal muscle-based disorders. For oncology treatment, more than 200 oligonucleotide drugs are in various phases of clinical trials.
By geography, the market in this report is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). The report includes detailed analyses of the major countries in these regions. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2021 through 2026.
The report also covers approved drugs, the oligonucleotide synthesis process, innovative research, opportunities within the market and profiles of leading companies in the oligonucleotide synthesis industry.
The Report Includes
Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
Evaluation of current market trends, and technological advancements within the industry and market share analysis of oligonucleotides by type, application, and region
Information on the classifications and applications of oligonucleotides and detailed description of DNA oligos and RNA oligos synthesis
Details of solid-phase chemical synthesis and alternative forms of oligonucleotide synthesis processes and insights into government regulations for oligonucleotide-based drugs
Information on CRISPR-Cas diagnosis and therapeutic tools for SARS-CoV-2 infection, and discussion on ASO as a COVID-19 therapeutic
A look at the new product developments, clinical trials, patents, mergers and acquisitions and collaborations or partnership of the industry
Company profiles of major players of the industry, including Agilent Technologies , Eurofins Scientific, Biolegio, Merck KGaA , Integrated DNA Technologies and Thermo Fisher Scientific
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
History of Oligonucleotide Synthesis
Solid Phase Synthesis
Types of Oligonucleotides
Oligonucleotide Synthesis Process
Solid Phase Chemical Synthesis
Alternative Forms of Oligonucleotide Synthesis
Chapter 4 Impact of COVID-19 on the Market
Impact of COVID-19 on the Market for Oligonucleotide Synthesis
CRISPR-Cas Diagnosis and Therapeutic Tools for SARS-CoV-2
ASO as a COVID-19 Therapeutic
Nucleic Acid Hybridization Using Microarray Process
Chapter 5 Market Breakdown by Product Type
Equipment and Reagents
Chapter 6 Market Breakdown by Application
Diagnostics and Therapeutics
Chapter 7 Market Breakdown by Region
Rest of Europe
Rest of Asia-Pacific
Rest of the World
Chapter 8 Industry Structure
Chapter 9 Company Profiles
Agilent Technologies Inc.
Biolytic Lab Performance Inc.
Integrated Dna Technologies Inc. (Danaher)
LC Sciences Llc
Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/gz740u
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900